$APEN News

Last published 3y ago

3y agoAPENHybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study - NCT05870943ClinicalTrials.govDurability assessed by blinded physician(s) with expertise in endoscopic sleeve gastroplasty (ESG) procedures graded according to a priori standardized criteria., %TBWL, %EWL, (and 8 more...)
3y agoAPEN BSXBOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022PR NewswireMARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on
3y agoAPEN BSXBoston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.PR NewswireAcquisition to expand endoluminal surgery portfolio and add differentiated technologies for endobariatric procedures MARLBOROUGH, Mass., Nov. 29, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) today
4y agoAPEN MDXG ARTCMIMEDX Announces Leadership TransitionGlobeNewswireK. Todd Newton Appointed as Interim Chief Executive Officer, Replacing Timothy R. Wright, Effective Immediately MARIETTA, Ga., Sept. 06, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company"), a transformational placen
4y agoAPENEndoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in MiamiACCESS NewswirePatients undergoing ESG achieved 24% total body weight loss in a bariatric surgery practice in a community setting. AUSTIN, TX / ACCESSWIRE / August 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medi
4y agoAPENApollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022ACCESS NewswireGrew global revenue 16% (20% in constant currency) as adoption increased across all product lines Secured FDA marketing authorization for Apollo ESGTM and Apollo REVISETM AUSTIN, TX / ACCESSWIRE / August 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (N
4y agoAPENApollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty ProcedureACCESS NewswirePublication of MERIT Study Follows FDA Market Authorization of Apollo ESG™ AUSTIN, TX / ACCESSWIRE / July 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bari
4y agoAPENApollo Endosurgery to Report Second Quarter Results on August 2, 2022ACCESS NewswireAUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Compan
4y agoAPENDigestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery ProductsACCESS NewswireAUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced highlights today from data presented at Digestive D
4y agoAPENApollo Endosurgery Products to Take Center Stage at Digestive Disease WeekACCESS NewswireAUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that Apollo products and procedures that util
4y agoAPENApollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022ACCESS NewswireGlobal revenue grew 20% year-over-year as adoption increased across all product lines AUSTIN, TX / ACCESSWIRE / May 3, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and ba
4y agoPLAN TWTR APEN TSLACNBC's Faber says it seems unlikely Musk will get private equity funding for Twitter purchaseCNBCFaber said the rates of return for private equity "don't work."
4y agoAPENApollo Endosurgery to Report First Quarter Results on May 3, 2022ACCESS NewswireAUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Compa
4y agoAPENApollo Endosurgery Appoints Jeannette Bankes to Board of DirectorsACCESS NewswireVeteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatr
4y agoAPENApollo Endosurgery to Participate in the Cowen Healthcare ConferenceACCESS NewswireAUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that Chas McKhann, CEO, and Jeff Black, CFO,
4y agoAPENApollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021ACCESS NewswireIncreased adoption across all product lines in both U.S. and international Grew fourth quarter 2021 revenue 26% AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical
4y agoAPENApollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022ACCESS NewswireAUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Co
4y agoAPENApollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market AccessACCESS NewswireVeteran Leader Brings 25 Years of Global Medical Device Experience AUSTIN, TX / ACCESSWIRE / January 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric p
4y agoAPENApollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020ACCESS NewswireFourth quarter 2021 revenue grew 25% over 2020 AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apollo" or the "Company") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedure
4y agoAPENApollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLCACCESS Newswire$35 million funded at close to refinance existing debt, extend maturity and lower interest expense Additional borrowing capacity provides minimally dilutive growth capital and strategic flexibility AUSTIN, TX / ACCESSWIRE / December 21, 2021 / Apollo
5y agoAPENApollo Endosurgery to Present at Four Upcoming Investor ConferencesACCESS NewswireAUSTIN, TX / ACCESSWIRE / November 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that management will participate in four
5y agoAPENApollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ETACCESS NewswireAUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the third quarter ended
5y agoAPENApollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking SystemACCESS NewswireStudy demonstrates high success rates, ease of use, and economic value in the treatment of GI defects AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices f
5y agoAPENApollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021ACCESS NewswireAUSTIN, TX / ACCESSWIRE / October 27, 2021 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Com
5y agoAPENApollo Endosurgery Announces Positive MERIT-Trial OutcomesACCESS NewswireTrial Results Demonstrate ESG Procedure Offers Significant and Durable Weight Loss, with Improvements in Obesity-Related Health Conditions MERIT-Trial met its primary endpoints for safety and efficacy, with patients undergoing the Endoscopic Sleeve Gas
5y agoAPENApollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional SharesACCESS NewswireAUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the closing of its previously announced underw
5y agoAPENApollo Endosurgery Announces Pricing of $65 Million Public Offering of Common StockACCESS NewswireAUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the pricing of its previously announced underw
5y agoAPENApollo Endosurgery Announces Commencement of Public Offering of Common StockACCESS NewswireAUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that it intends to offer and sell shares of it
5y agoAPENApollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business UpdatesACCESS NewswireRevenue expected between $16.0 million and $16.4 million Third consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30% Submitted a De Novo 510(k) Classification Request to FDA for Apollo ESG™ for weight loss and Apollo RE
5y agoAPENApollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth ConferenceACCESS NewswireAUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in
5y agoAPENApollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ETACCESS NewswireAUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended J
5y agoAPENApollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021ACCESS NewswireAUSTIN, TX / ACCESSWIRE / July 27, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is schedule
5y agoAPENApollo Endosurgery Appoints Jeffrey G. Black as Chief Financial OfficerACCESS NewswireVeteran Executive Brings 30 Years of Financial and Operational Leadership Experience AUSTIN, TX / ACCESSWIRE / July 16, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal
5y agoAPENMERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety EndpointsACCESS NewswireAUSTIN, TX / ACCESSWIRE / June 14, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced that investigators of the Multi-Center ESG Randomi
5y agoAPENApollo Endosurgery to Present at June Investor ConferencesACCESS NewswireAUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that management will participate in two investor c
5y agoAPENApollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021ACCESS NewswireAUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced highlights from Digestive Disease Week (DDW) 2021 w
5y agoABML ACU AFI ALOT+52Sidoti Microcap Virtual ConferenceACCESS NewswireMay 19 - 20, 2021 Presentation times and weblinks released for over 60 presenting companies NEW YORK, NY / ACCESSWIRE / May 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day spring Microcap Virtual Con
5y agoAPENApollo Endosurgery to Present at Sidoti Conference May 20ACCESS NewswireAUSTIN, TX / ACCESSWIRE / May 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that it will participate in the Sidoti & Company Vi
5y agoAPENApollo Endosurgery, Inc. Reports 29% Increase in First Quarter RevenueACCESS NewswireConference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, TX / ACCESSWIRE / May 4, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric proced
5y agoAPENApollo Endosurgery, Inc. to Host Earnings CallACCESS NewswireNEW YORK, NY / ACCESSWIRE / May 4, 2021 / Apollo Endosurgery, Inc. (NASDAQ:APEN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 4, 2021 at 4:30 PM Eastern Time. To listen to the event live or access
5y agoAPEN APO AMEH VZAbout 1.5 million people still pay for AOL — but now they get tech support and identity theft services instead of dial-up internetCNBCAbout 1.5 million people still pay for AOL, but now they get tech support and identity theft services for their money.
5y agoAGEN APEN IGMS MDXG+1MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for ShareholdersGlobeNewswireUrges Shareholders to Vote the WHITE Proxy Card "FOR ALL" Four of MIMEDX's Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner Entirely Reconstituted Board and New Management Team Positioned Com
5y agoAPENApollo Endosurgery Announces Appointments to Commercial Leadership TeamACCESS NewswireKirk Ellis to Serve as Vice President of US Sales Steve Bosrock to Serve as Vice President of Marketing & Medical Education AUSTIN, TX / ACCESSWIRE / May 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasiv
5y agoAPENApollo Endosurgery to Report First Quarter Financial Results on May 4, 2021ACCESS NewswireAUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is schedul
5y agoAPENApollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking SystemACCESS NewswireAuthors conclude, "Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closure, including durable sealing of full-thickness perforation."
5y agoAPENNew patent application published for: Endoscopic Suturing SystemUS Patent Applications (USPTO)( 1 of 1 )
5y agoAPENApollo Endosurgery Announces Inducement GrantACCESS NewswireApollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for and bariatric procedures, announced the terms of equity awards granted to Chas McKhann in connection with his appointment as the company's CEO in March 2021. The company's board of directors granted Chas a stock option to purchase an aggregate of 848,733 shares of common stock, at a per sha ...
5y agoAPENApollo Endosurgery announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon ProceduresACCESS NewswireApollo Endosurgery, Inc. ("Apollo") , a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the assignment of Category I Current Procedural Terminology (CPT®) codes with short form descriptor esophagogastroduodenoscopy with deployment of gastric bariatric device (e.g., balloon) under endoscopic guidance. The codes and descriptor will be used ...
5y agoAPENApollo Endosurgery Receives FDA Breakthrough Device Designation for the Orbera(R) Intragastric Balloon for Treatment of Patients with NASHACCESS NewswireApollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that it has received a Breakthrough Device Designation from the U.S. Food and Drug Administration for the Orbera® Intragastric Balloon, specifically for the indication for use in treating patients with BMI between 30-40 kg/m2 with n ...
5y agoAPENApollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2020 ResultsACCESS NewswireConference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET